The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...
The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
Whole grains and fruits are in, and added sugar is out. That’s going to change what’s on a lot of cereal boxes and other things ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce trigl ...
The FDA has approved the first generic liraglutide indicated to improve glycemic control in adults and pediatric patients ...
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).